Squadron Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
Squadron Capital Management's ORIC Position: Q3 2026 in Review
Squadron Capital Management opened a new position in Oric Pharmaceuticals (ORIC) in Q3 2026: 1,000,000 shares worth $13.5M. The stake represents 3.38% of the portfolio and ranks #9 among its holdings.
203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- Squadron Capital Management held 1,000,000 shares of Oric Pharmaceuticals worth $13.5M as of Q3 2026.
- Oric Pharmaceuticals was a new Squadron Capital Management position in Q3 2026.
- Oric Pharmaceuticals made up 3.38% of Squadron Capital Management's portfolio in Q3 2026, its #9 holding.
- 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on Squadron Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.